AudioSense Hearing, Balance & Concussion Celebrates Move to a New Exciting Location and Expanding Team
Toronto, Jan. 21, 2022 (GLOBE NEWSWIRE) -- An estimated 1.5 billion people across the globe experience some level of difficulty...
Year: 2022
Urban Reproductive Health Provides Comprehensive, Trusted Reviews of Top Male Enhancement Products
Tampa, Jan. 21, 2022 (GLOBE NEWSWIRE) -- There is now a place for men to discover discreet, trustworthy, vetted advice...
Assure Announces Voluntary Delisting from TSX Venture Exchange
DENVER, Jan. 21, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM; TSXV: IOM), a provider...
Arch Oncology Receives U.S. FDA Orphan Drug Designation for AO-176, a Next-Generation Anti-CD47 IgG2 Antibody, for the Treatment of Multiple Myeloma
BRISBANE, Calif. and ST. LOUIS, Jan. 21, 2022 (GLOBE NEWSWIRE) -- Arch Oncology, Inc., a clinical-stage immuno-oncology company focused on...
Caleb DesRosiers, JD, MPA Appointed to Daxor Corporation Board of Directors
Oak Ridge, TN, Jan. 21, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement...
22nd Century Group Appoints James A. Mish to Its Board of Directors
Further enhances the Board’s scientific and commercialization experience supporting key market launchesBUFFALO, N.Y, Jan. 21, 2022 (GLOBE NEWSWIRE) -- 22nd...
Orchard Therapeutics Announces Publication in The Lancet of Long-term Clinical Outcomes with Libmeldy for the Treatment of Children with Early-onset MLD
Administration of one-time hematopoietic stem cell (HSC) gene therapy resulted in sustained, clinically meaningful benefits by preserving cognitive function and...
Sorrento Therapeutics Announces Covishield (Sti-9167), a Broad-Spectrum Neutralizing Antibody, Potently Neutralizes Omicron and Omicron (+R346k) Variants of Sars-Cov-2
COVISHIELD (STI-9167) neutralizing antibody (nAb) was discovered by scientists from the Icahn School of Medicine at Mount Sinai (“Icahn Mount...
Sosei Heptares Webinar Presentation for FY2021 Financial Results
TOKYO, Japan and CAMBRIDGE, United Kingdom, Jan. 21, 2022 (GLOBE NEWSWIRE) -- Sosei Group Corporation (“the Company”; TSE: 4565) will...
Nicox Provides Fourth Quarter 2021 Business and Financial Highlights
Press ReleaseNicox Provides Fourth Quarter 2021 Business and Financial HighlightsMont Blanc Phase 3 clinical trial of NCX 470 in glaucoma...
iCRYO Partners With 24 Hour Fitness
Fitness Industry Giant And Recovery Leader Come Together To Provide Full Body Wellness To 24 Hour Fitness Members HOUSTON, TEXAS,...
Clover’s Final SPECTRA Phase 2/3 Clinical Trial Efficacy Data Is Published in The Lancet
CHENGDU, China, Jan. 21, 2022 (GLOBE NEWSWIRE) -- Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global clinical-stage biotechnology company developing...
Extendicare Announces Timing of 2021 Fourth Quarter Results and Year End Results and Conference Call
MARKHAM, Ontario, Jan. 20, 2022 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that it...
Opiant Pharmaceuticals Announces First Patient Dosed in Phase 2 Trial of OPNT002, Nasal Naltrexone, for Alcohol Use Disorder
Phase 2 trial to evaluate reduction in heavy drinking as measured by a change in the World Health Organization drinking...
Correction: Opiant Pharmaceuticals Corrects Error in Issuing Duplicate Press Release Today
SANTA MONICA, Calif., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Correction: Opiant Pharmaceuticals, Inc. (“Opiant” or “Company”) (NASDAQ: OPNT), a specialty...
Kraig Biocraft Laboratories Closes Additional Funding Agreement
Robust financial strength positions Company to deploy Impact CapitalANN ARBOR, Mich., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories,...
Bioasis Announces Filing of Its Quarter and Financial Statements and MD&A for the Period Ending November 30, 2021
NEW HAVEN, Conn., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Bioasis Technologies Inc. (TSX.V:BTI; OTCQB:BIOAF) (the “Company” or “Bioasis”), a biopharmaceutical company...
Circulating Tumor Cell (CTC) Isolation with TellDx Technology Could Inform Personalized Drug Treatment in Prostate Cancer
-- Single-cell proteomics can elucidate kinase activity in prostate cancer models -- -- Kinase activity in bone metastases and epithelial...
Rapid Micro Biosystems Appoints Michael Beaulieu as Vice President, Investor Relations and Corporate Communications
LOWELL, Mass., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences...
Conformis, Inc. to Release Fourth Quarter and Fiscal Year 2021 Financial Results on March 2, 2022
BILLERICA, Mass., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today that as mentioned on its Business...
